Thambi Paul M, MD in Baltimore: Medical Oncologist at Johns Hopkins
Thambi Paul M, MD is a medical oncologist at Johns Hopkins Medicine, one of Baltimore's two dominant cancer care systems. He specializes in treating solid tumors, particularly gastrointestinal and thoracic cancers. Patients typically reach him through referral after a primary oncology diagnosis at Johns Hopkins or through self-referral if they already hold Johns Hopkins patient status.
What He Actually Treats
Dr. Paul focuses on systemic chemotherapy and targeted therapy for cancers of the stomach, esophagus, colon, lung, and related organs. He also takes on cases with mixed tumor histologies where gastrointestinal or thoracic features dominate. He does not perform surgery or radiation; those specialties exist within Johns Hopkins but as separate departments. His role is to manage medical oncology protocols, which may involve single or combination chemotherapy, immunotherapy, or enrollment in clinical trials.
Insurance, Referrals, and Appointment Access
Dr. Paul operates within Johns Hopkins Medicine, which participates in most major Maryland health plans, including CareFirst BlueCross BlueShield, Aetna, Cigna, and others. Verification of coverage should happen before the first appointment, as deductibles and out-of-pocket maximums vary by plan. Patients typically need an oncology referral from a primary care doctor or surgeon, though patients already under Johns Hopkins oncology can self-refer to Dr. Paul for a second opinion or specialty consultation. New-patient appointment lead times average 2 to 4 weeks, though urgent cases may be expedited. Johns Hopkins oncology clinics do not accept walk-ins; all visits are scheduled.
How He Compares to Other Baltimore Oncologists
Baltimore is served primarily by Johns Hopkins and University of Maryland Medical Center, the two systems with full oncology departments. Within Johns Hopkins, Dr. Paul represents a subspecialty focus on gastrointestinal and thoracic tumors; other Johns Hopkins medical oncologists serve breast, hematologic, or general oncology populations. University of Maryland also employs board-certified medical oncologists with overlapping expertise. For patients with insurance that excludes Johns Hopkins, or for a second opinion outside the Hopkins system, University of Maryland represents the main local alternative. Neither system is uniformly superior; quality depends on individual physician expertise, and the choice often hinges on insurance network status and referral pathways already in place.
What the First Appointment Involves
Patients should bring pathology reports, imaging results (CT or MRI films, not just the radiologist's summary), and a list of current medications. Dr. Paul will review the tumor stage and type, discuss treatment options (which may include chemotherapy, targeted agents, immunotherapy, or clinical trials), and outline expected side effects and monitoring schedules. If the patient has not yet seen a surgical or radiation oncologist, he will recommend those consultations if relevant. The appointment typically lasts 45 to 60 minutes. Subsequent visits, if chemotherapy is chosen, are shorter unless a new problem emerges.
Hours, Location, and Parking
Dr. Paul sees patients at Johns Hopkins Kimmel Cancer Center, located at 1650 W. Baltimore Street in Baltimore's Paca-Pratt neighborhood. The center operates Monday through Friday, 8 a.m. to 5 p.m., with some early morning slots available. Saturday and evening appointments are not offered. Parking is available in a Johns Hopkins lot adjacent to the building; validation is provided for cancer center visits. The lot fills on weekday mornings, so arriving 15 minutes early is advisable. Johns Hopkins also offers valet parking for an additional fee.
Who This Fits and Who It Does Not
This setting suits patients with gastrointestinal or thoracic cancers who have Johns Hopkins insurance coverage or who prioritize Johns Hopkins' research protocols and clinical trials. It also fits patients who have already begun treatment elsewhere and want a Johns Hopkins specialty consultation. It does not suit patients who need same-day or walk-in oncology care, or those without Johns Hopkins network access. Patients with breast, blood, or other non-GI/thoracic tumors may find equally qualified specialists within Johns Hopkins but outside Dr. Paul's personal focus.
Dr. Paul's position at Johns Hopkins reflects Baltimore's concentration of cancer care within two systems. His subspecialty depth in gastrointestinal oncology positions him as a logical referral target for patients with those diagnoses and insurance access to Hopkins.
